Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

Monlunabant is under clinical development by Inversago Pharma and currently in Phase II for Hypertriglyceridemia.

Just when you thought there couldn’t be investor appetite for yet another GLP-1-focused obesity biotech, Verdiva Bio has ...

How to use virtual reality in simulated practice to teach medicines management to nursing students Education on medication safety is an important part of reducing medication errors. Simulation ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Asthma is a disease of the lungs that affects people of all ages and both sexes. About 1 in 13 people in the United States ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Globally, the prevalence of asthma continues to increase and exercise-induced bronchoconstriction (EIB) affects the vast majority. Managing asthma effectively is an essential prerequisite to ...

The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...

Results: Zolmitriptan was detected in plasma 2 minutes after intranasal administration in the majority of subjects (~75%) compared with 10 minutes after oral administration. The intranasal:tablet ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca ... most common adverse events recorded included headache, oral candidiasis, cough, and dysphonia. The new approval ...

Gaming tablets offer more than just a screen for play. These devices need to juggle productivity features and entertainment options to make their prices worthwhile, all while still offering a high ...